You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Anitocabtagene autoleucel for treating relapsed or refractory multiple myeloma ID6549
Topic prioritisation
Project information
Project documents
35154-Anitocabtagene-Autoleucel-for-Multiple-Myeloma-V1.0-DEC2024-NON-CONF.pdf
Back to top